Pure Global AI
NCT06325813Not yet recruiting

ADHD PreSMA Response Inhibition Therapy

Children's Hospital Medical Center, CincinnatiClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Attention Deficit Hyperactivity Disorder
Drug/Device/Intervention
Active repetitive TMS
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Children's Hospital Medical Center, Cincinnati
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Dec 31, 2026
Enrollment
40 participants
Primary outcome

TMS-based Short-Interval Intracortical Inhibition (SICI),EEG-based beta activity,TMS-based Cortical Silent Period (cSP),EEG-based alpha activity

Summary

ADHD children have abnormal inhibitory control, meaning they have trouble stopping themselves
 from doing something they should not do. This ability to control involves an area in the
 brain called the pre-supplementary motor area (pre-SMA). Scientists have previously shown
 that the pre-SMA is abnormal in ADHD patients. In this study, we will use Transcranial
 Magnetic Stimulation (TMS) to stimulate the pre-SMA and determine the effects on measures
 that are related to inhibitory control.

ICD-10 classifications
Neurotic disorder, unspecifiedHyperkinetic disorder, unspecifiedHabit and impulse disorder, unspecifiedMild cognitive disorderDisturbance of activity and attention
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06325813
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06325813 through Pure Global AI's free database. This phase not specified trial is sponsored by Children's Hospital Medical Center, Cincinnati and is currently Not yet recruiting. The study focuses on Attention Deficit Hyperactivity Disorder. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.